News | December 21, 2022
Indira IVF forays into diagnostic business with ‘Indira Pathlabs’
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Global pharmaceutical company having a surgical business concept incepted in Dubai
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
Sanjeev is currently the Country President for AstraZeneca Malaysia
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
To focus on providing safer burn treatments for women and armed forces
The service includes full fertility care benefits, including egg and embryo freezing options to employees
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
Subscribe To Our Newsletter & Stay Updated
